A. Möller (Zürich, Switzerland), M. Stahl (Berlin, Germany)
Estimating the minimum sample size for interventional research using the lung clearance index
C. Bowerman (Hamilton, Canada), F. Ratjen (Toronto, Canada), S. Stanojevic (Halifax, Canada)
|   |
Longitudinal LCI in infants with CF using a portable multiple breath washout (LIMBuS study)
C. Nissenbaum (Manchester, United Kingdom), D. Weiner (Pittsburgh, United States), L. Healy (Manchester, United Kingdom), A. Shawcross (Manchester, United Kingdom), C. Fullwood (Manchester, United Kingdom), R. Thursfield (Liverpool, United Kingdom), C. Murray (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom)
| |
Respiratory symptom scores to capture acute respiratory events in children with cystic fibrosis
L. Perrem (Toronto (ON), Canada), S. Stanojevic (Halifax, Canada), M. Shaw (Toronto (ON), Canada), M. Solomon (Toronto (ON), Canada), H. Grasemann (Toronto (ON), Canada), N. Sweezey (Toronto (ON), Canada), V. Waters (Toronto (ON), Canada), S. Davis (Chapel Hill, United States), D. Sanders (Indiana, United States), F. Ratjen (Toronto (ON), Canada)
| |
Impact of Pseudomonas aeruginosa antibiotic eradication therapy on lung function decline in cystic fibrosis
I. Gascon Casaredi (Barcelona, Spain), M. Shaw (Toronto, Canada), V. Waters (Toronto, Canada), R. Seeto (Toronto, Canada), A. Blanchard (Montreal, Canada), F. Ratjen (Toronto, Canada)
| |
Automated airway-artery analysis on chest CT confirms positive effect of inhaled hypertonic saline in preschool children with cystic fibrosis
Y. Chen (Rotterdam, Netherlands), Q. Lv (Rotterdam, Netherlands), E. Andrinopoulou (Rotterdam, Netherlands), L. Gallardo-Estrella (Nijmegen, Netherlands), J. Charbonnier (Nijmegen, Netherlands), D. Caudri (Rotterdam, Netherlands), S. Davis (Rotterdam, Netherlands), M. Rosenfeld (Rotterdam, Netherlands), F. Ratjen (Toronto, Canada), R. Kronmal (Seattle, United States), K. Hinckley Stukovsky (Seattle, United States), S. Stick (Rotterdam, Australia), H. Tiddens (Rotterdam, Netherlands)
| |
The clinical effectiveness and validity of home spirometry in children with cystic fibrosis
P. Lawrence (Liverpool (Merseyside), United Kingdom), S. Mayell (Liverpool (Merseyside), United Kingdom), R. Thursfield (Liverpool (Merseyside), United Kingdom)
| |
Lung ultrasound value in cystic fibrosis consolidation and atelectasis detection
D. Popin (Timisoara, Romania), I. Ciuca (Timisoara, Romania), M. Dediu (Timisoara, Romania), E. Stoicescu (Timisoara, Romania), L. Pop (Timisoara, Romania), I. Ciuca (Timisoara (Timis), Romania)
| |
Characterization of a signal-correction error in a commercial multiple-breath washout device
M. Oestreich (Bern, Switzerland), F. Wyler (Bern, Switzerland), B. Etter (Bern, Switzerland), K. Ramsey (Bern, Switzerland), P. Latzin (Bern, Switzerland)
| |
Lung clearance index and nutritional status in cystic fibrosis children
M. Dediu (Timisoara, Romania), D. Popin (Timisoara, Romania), L. Pop (Timisoara, Romania), I. Ciuca (Timisoara, Romania), I. Ciuca (Timisoara (Timis), Romania)
| |
Comparison of sensor crosstalk-corrected N2 versus SF6 multiple breath washout outcomes
A. Phanthanourak (Toronto, Canada), R. Jensen (Toronto, Canada), M. Shaw (Toronto, Canada), R. Chen (Toronto, Canada), F. Adil (Toronto, Canada), D. Niththiyanandan (Toronto, Canada), S. Stanojevic (Halifax, Canada), F. Ratjen (Toronto, Canada)
| |
Feasibility of telehealth spirometry for patients with cystic fibrosis in a regional setting
E. Hatziagorou (Thessaloniki, Greece), A. Sopiadou (Thessaloniki, Greece), C. Kogias (Thessaloniki, Greece), M. Gioulvanidou (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), I. Kalaitzopoulou (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece)
| |
One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?
S. Uytun (Ankara, Turkey), S. Eryilmaz Polat (Ankara, Turkey), S. Özkan Tabakçi (Ankara, Turkey), G. Cinel (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), . Yalçin (Ankara, Turkey), N. Kiper (Ankara, Turkey), V. Sen (Diyarbakir, Turkey), D. Altintas (Adana, Turkey), H. Çokugras (Istanbul, Turkey), A. Kilinç (Istanbul, Turkey), H. Yazan (Istanbul, Turkey), A. Çollak (Istanbul, Turkey), S. Uzuner (Istanbul, Turkey), G. Ünal (Konya, Turkey), A. Yilmaz (Konya, Turkey), S. Çelik (Konya, Turkey), E. Damadoglu (Ankara, Turkey), I. Irmak (Ankara, Turkey), E. Demir (Izmir, Turkey), G. Öztürk (Izmir, Turkey), E. Basaran (Antalya, Turkey), A. Bingöl (Antalya, Turkey), N. Sapan (Bursa, Turkey), A. Aslan (Ankara, Turkey), P. Asfuroglu (Ankara, Turkey), K. Harmanci (Eskisehir, Turkey), M. Köse (Kayseri, Turkey), M. Hangül (Kayseri, Turkey), A. Özdemir (Mersin, Turkey), G. Özcan (Ankara, Turkey), Z. Gayretli (Trabzon, Turkey), Ö. Keskin (Gaziantep, Turkey), H. Yüksel (Manisa, Turkey), S. Özdogan (Istanbul, Turkey), E. Topal (Malatya, Turkey), G. Çaltepe (Samsun, Turkey), D. Can (Balikesir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), M. Kiliç (Elazig, Turkey), A. Süleyman (Istanbul, Turkey), T. Sismanlar Eyüboglu (Ankara, Turkey), S. Pekcan (Konya, Turkey), N. Çobanoglu (Ankara, Turkey), E. Çakir (Istanbul, Turkey), U. Özçelik (Ankara, Turkey), D. Dogru (Ankara, Turkey)
| |
The effect of breathing exercise on the quality of life of 3-12 years old childrens with cystic fibrosis and their families
M. Kalyoncu (Istanbul, Turkey), H. Mursaloglu (Istanbul, Turkey), Z. Yerlikaya (Istanbul, Turkey), C. Yilmaz Yegit (Istanbul, Turkey), M. Yanaz (Istanbul, Turkey), A. Gulieva (Istanbul, Turkey), B. Uzunoglu (Istanbul, Turkey), G. Tastan (Istanbul, Turkey), A. Ergenekon (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), Y. Gökdemir (Istanbul, Turkey), F. Karakoç (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)
| |
Increased diagnostic value of LCI in pulmonary exacerbations in cystic fibrosis paediatric patients using the corrected Exhalyzer software.
I. Wojsyk-Banaszak (Poznan, Poland), B. Wieckowska (Poznan, Poland), Z. Stachowiak (Poznan, Poland), M. Andrzejewska (Poznan, Poland), A. Szczepankiewicz (Poznan, Poland)
| |
Assessing the utility of home spirometry for managing children with cystic fibrosis during COVID-19 pandemic
B. Babu (Birmingham, United Kingdom), B. Heyeer (Birmingham, United Kingdom), C. Mcardle (Birmingham, United Kingdom), B. Davies (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom), M. Desai (Birmingham, United Kingdom)
| |
The efficacy of inhaled hypertonic saline in children with cystic fibrosis who receive daily DNase.
M. Gencoglu (Ankara, Turkey), G. Tugcu (Ankara, Turkey), S. Akyan Soydas (Ankara, Turkey), G. Cinel (Ankara, Turkey), N. Emiralioglu (Ankara, Turkey), E. Yalçin (Ankara, Turkey), N. Kiper (Ankara, Turkey), V. Sen (Diyarbakir, Turkey), D. Ufuk Altintas (Adana, Turkey), H. Çokugras (Istanbul, Turkey), A. Ayzit Kilinç (Istanbul, Turkey), H. Yazan (Istanbul, Turkey), G. Ünal (Konya, Turkey), . Yilmaz (Konya, Turkey), H. Çaglar (Konya, Turkey), E. Damadoglu (Ankara, Turkey), I. Irmak (Ankara, Turkey), . Demir (Izmir, Turkey), G. Öztürk (Izmir, Turkey), . Bingöl (Antalya, Turkey), E. Basaran (Antalya, Turkey), N. Sapan (Bursa, Turkey), A. Aslan (Ankara, Turkey), P. Asfuroglu (Ankara, Turkey), K. Harmanci (Eskisehir, Turkey), . Köse (Kayseri, Turkey), M. Hangül (Kayseri, Turkey), A. Özdemir (Mersin, Turkey), . Özcan (Ankara, Turkey), Z. Gayretli (Trabzon, Turkey), . Keskin (Gaziantep, Turkey), H. Yüksel (Manisa, Turkey), S. Özdogan (Istanbul, Turkey), . Topal (Malatya, Turkey), G. Çaltepe (Samsun, Turkey), . Can (Balikesir, Turkey), P. Korkmaz Ekren (Izmir, Turkey), M. Kiliç (Elazig, Turkey), . Sismanlar Eyüboglu (Ankara, Turkey), . Pekcan (Konya, Turkey), N. Çobanoglu (Ankara, Turkey), . Çakir (Istanbul, Turkey), U. Özçelik (Ankar, Turkey), D. Dogru (Ankar, Turkey)
| |